Latest filing published 10 Jun 2026 for Collegium Pharmaceutical, INC. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by Gino Santini span 3 companies, the busiest being Collegium Pharmaceutical, Inc, Horizon Therapeutics Public Ltd Co and Intercept Pharmaceuticals, Inc. The record holds 16 filings, for trades running from 20 May 2021 to 8 June 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 10 June 2026, reports an option exercise in Collegium Pharmaceutical, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16 of 16 declarations